Legionella pneumophila replication in macrophages inhibited by selective immunomodulatory effects on cytokine formation by epigallocatechin gallate, a major form of tea catechins

被引:51
作者
Matsunaga, K [1 ]
Klein, TW [1 ]
Friedman, H [1 ]
Yamamoto, Y [1 ]
机构
[1] Univ S Florida, Coll Med, Dept Med Microbiol & Immunol, Tampa, FL 33612 USA
关键词
D O I
10.1128/IAI.69.6.3947-3953.2001
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Epigallocatechin gallate (EGCg) is a major form of tea catechin and has a variety of biological activities, including antitumor as well as antimicrobial activity against some pathogens. Although the biological activities of EGCg have been extensively studied, its immunological effects are not well known. In the present study, the ability of EGCg to modulate macrophage immune functions in an in vitro Legionella pneumophila infection model of macrophages was examined. The study showed that EGCg inhibited the growth of L. pneumophila in macrophages at a concentration as low as 0.5 mug/ml without any direct antibacterial effect on the organisms. The EGCg selectively upregulated the production of interleukin-12 (IL-12) and tumor necrosis factor alpha (TNF-alpha) and downregulated IL-10 production of macrophages induced by L. pneumophila infection in a dose-dependent manner, but did not alter IL-6 production even at a high dose. The upregulation of the levels of macrophage gamma interferon (IFN-gamma) mRNA by EGCg was also demonstrated. Treatment of macrophage cultures with anti-TNF-a and anti-IFN-gamma monoclonal antibodies markedly abolished the anti-L. pneumophila activity of macrophages induced by the EGCg treatment. These results indicate that EGCg selectively alters the immune responses of macrophages to L. pneumophila and leads to an enhanced anti-L. pneumophila activity of macrophages mediated by enhanced production of both TNF-alpha and IFN-gamma. However, the enhancement of in vitro anti-L. pneumophila activity by EGCg may not be directly mediated by IL-10 and IL-12 production modulation. Thus, the results of this study revealed the immunomodulatory effect of EGCg on macrophages, which have a critical role in infections.
引用
收藏
页码:3947 / 3953
页数:7
相关论文
共 44 条
  • [1] TRANSFORMING GROWTH-FACTOR-BETA IN LEISHMANIAL INFECTION - A PARASITE ESCAPE MECHANISM
    BARRALNETTO, M
    BARRAL, A
    BROWNELL, CE
    SKEIKY, YAW
    ELLINGSWORTH, LR
    TWARDZIK, DR
    REED, SG
    [J]. SCIENCE, 1992, 257 (5069) : 545 - 548
  • [2] BHARDWAJ N, 1986, J IMMUNOL, V137, P2662
  • [3] DENIS M, 1993, J IMMUNOL, V151, P5425
  • [4] Induction of gamma interferon production in human alveolar macrophages by Mycobacterium tuberculosis
    Fenton, MJ
    Vermeulen, MW
    Kim, S
    Burdick, M
    Strieter, RM
    Kornfeld, H
    [J]. INFECTION AND IMMUNITY, 1997, 65 (12) : 5149 - 5156
  • [5] STIMULATION OF ANTIBACTERIAL MACROPHAGE ACTIVITIES BY B-CELL STIMULATORY FACTOR-II (INTERLEUKIN-6)
    FLESCH, IEA
    KAUFMANN, SHE
    [J]. INFECTION AND IMMUNITY, 1990, 58 (01) : 269 - 271
  • [6] LEGIONELLA-PNEUMOPHILA-INDUCED BLASTOGENESIS OF MURINE LYMPHOID-CELLS INVITRO
    FRIEDMAN, H
    WIDEN, R
    KLEIN, T
    SEARLS, L
    CABRIAN, K
    [J]. INFECTION AND IMMUNITY, 1984, 43 (01) : 314 - 319
  • [7] A RAPID COLORIMETRIC ASSAY FOR EVALUATING LEGIONELLA-PNEUMOPHILA GROWTH IN MACROPHAGES IN-VITRO
    GEBRAN, SJ
    NEWTON, CA
    YAMAMOTO, Y
    KLEIN, TW
    FRIEDMAN, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (01) : 127 - 130
  • [8] IFN-γ expression in macrophages and its possible biological significance
    Gessani, S
    Belardelli, F
    [J]. CYTOKINE & GROWTH FACTOR REVIEWS, 1998, 9 (02) : 117 - 123
  • [9] ANTIOXIDATIVE EFFECT OF POLYPHENOL EXTRACT PREPARED FROM VARIOUS CHINESE TEAS
    HO, CT
    CHEN, QY
    SHI, HA
    ZHANG, KQ
    ROSEN, RT
    [J]. PREVENTIVE MEDICINE, 1992, 21 (04) : 520 - 525
  • [10] LEGIONNAIRES-DISEASE BACTERIUM (LEGIONELLA-PNEUMOPHILA) MULTIPLIES INTRACELLULARLY IN HUMAN-MONOCYTES
    HORWITZ, MA
    SILVERSTEIN, SC
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 1980, 66 (03) : 441 - 450